Search Results

INTRODUCTION : The National Cancer Comprehensive Network (NCCN) has advised vaccination against COVID-19 in all patients undergoing chemotherapy and immunotherapy. There is limited data on how cancer-targeted therapies impact COVID-19

Objective: The COVID-19 pandemic has had an unprecedented impact on healthcare delivery systems. Surgery, anesthesia, emergency, and intensive care services have been heavily affected by the pandemic. Multiple national surgical organizations in the

. Strategies to divert patients away from the ED are needed, especially in the setting of COVID-19, which has disrupted usual care provision and exposed already vulnerable cancer patients to even greater risk. At the James Cancer Hospital, we have implemented

progression, and increased risk of COVID-19 mortality. We conducted a single-center descriptive study with an aim to identify the effect of COVID-19 on treatment delay in patients receiving immune checkpoint inhibitors (ICI). Methods : A retrospective chart

, effecting real change on patient circumstances falls to institutions. This is an especially important consideration in the current global environment. The COVID-19 pandemic represents an unprecedented health and economic crisis that will have far

INTRODUCTION : Severe acute respiratory syndrome coronavirus (SARS-CoV-2) has affected over two hundred million people. Numerous studies have evaluated its impact on cancer patients in regards to COVID-19 severity and outcome. However, there is

INTRODUCTION : During the COVID-19 pandemic, data suggests there was a significant decrease in the volume of cancer screening tests and number of cancer diagnoses made compared with historical trends. Given the association of late stage cancer

Colorectal cancer (CRC) screening of uninsured and medically underserved South Carolinians has been the goal of Colorectal Cancer Prevention Network (CCPN) for 12 years. Due to COVID19, screening was halted for 3 months. Two fecal immunochemical

Background: The COVID-19 pandemic presents unique challenges in breast cancer (BC) management. Clinicians at our institution along with members from COVID-19 breast cancer consortium, published and adopted practice guidelines assigning patients to

, covering screening eligibility and follow-up guidelines, navigating screening referral, and smoking cessation. Screening increased 18% following implementation of I-STEP. The COVID-19 pandemic prompted unforeseen changes to the healthcare landscape, wherein